Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice.
- Published in:
- Gene Therapy, 2000, v. 7, n. 24, p. 2099, doi. 10.1038/sj.gt.3301334
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2000 AND VI 7 AND IP 24
Results: 14
1
2
Virus-like gene transfer into cells mediated by polyoma virus pseudocapsids.
- Published in:
- Gene Therapy, 2000, v. 7, n. 24, p. 2122, doi. 10.1038/sj.gt.3301322
- By:
- Publication type:
- Article
3
Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
- Published in:
- Gene Therapy, 2000, v. 7, n. 24, p. 2071, doi. 10.1038/sj.gt.3301327
- By:
- Publication type:
- Article
4
Direct intra-cardiomuscular transfer of β<sub>2</sub>-adrenergic receptor gene augments cardiac output in cardiomyopathic hamsters.
- Published in:
- Gene Therapy, 2000, v. 7, n. 24, p. 2087, doi. 10.1038/sj.gt.3301329
- By:
- Publication type:
- Article
5
Persistent, antigen-specific, therapeutic antitumor immunity by dendritic cells genetically modified with an adenoviral vector to express a model tumor antigen.
- Published in:
- Gene Therapy, 2000, v. 7, n. 24, p. 2080, doi. 10.1038/sj.gt.3301336
- By:
- Publication type:
- Article
6
Demyelination but no cognitive, motor or behavioral deficits after adenovirus-mediated gene transfer into the brain.
- Published in:
- Gene Therapy, 2000, v. 7, n. 24, p. 2094, doi. 10.1038/sj.gt.3301346
- By:
- Publication type:
- Article
7
Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells.
- Published in:
- Gene Therapy, 2000, v. 7, n. 24, p. 2105, doi. 10.1038/sj.gt.3301347
- By:
- Publication type:
- Article
8
Adenoviral vector design for high-level transgene expression in primitive human hematopoietic progenitors.
- Published in:
- Gene Therapy, 2000, v. 7, n. 24, p. 2132, doi. 10.1038/sj.gt.3301352
- By:
- Publication type:
- Article
9
Enhancement of antitumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines.
- Published in:
- Gene Therapy, 2000, v. 7, n. 24, p. 2113, doi. 10.1038/sj.gt.3301353
- By:
- Publication type:
- Article
10
A novel doxycycline inducible autoregulatory plasmid which displays ‘on’/‘off’ regulation suited to gene therapy applications.
- Published in:
- Gene Therapy, 2000, v. 7, n. 24, p. 2061, doi. 10.1038/sj.gt.3301354
- By:
- Publication type:
- Article
11
Exploring vascular heterogeneity for gene therapy targeting.
- Published in:
- 2000
- By:
- Publication type:
- Editorial
12
Acknowledgement to Referees.
- Published in:
- Gene Therapy, 2000, v. 7, n. 24, p. 2139, doi. 10.1038/sj.gt.3301380
- Publication type:
- Article
13
Author Index.
- Published in:
- Gene Therapy, 2000, v. 7, n. 24, p. 2141, doi. 10.1038/sj.gt.3301381
- Publication type:
- Article
14
Keyword Index.
- Published in:
- Gene Therapy, 2000, v. 7, n. 24, p. 2147, doi. 10.1038/sj.gt.3301382
- Publication type:
- Article